Bionomics Limited

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Biotechnology
  • Company website

Company description

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a vascular disrupting agent, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer, and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited has a licensing agreement with Merck & Co., Inc. The company was incorporated in 1996 and is based in Eastwood, Australia.

Financial highlights

Market Capitalization$89.3211 million
P/E Ratio
P/E Growth Ratio0
Book Value0.046
Dividend Per Share0
Earnings Per Share-0.017
EBITDA255.158
Profit Margin0
Operating Margin TTM-36.0341
Return on Assets TTM-0.2264
Return on Equity TTM-0.5693
Revenue TTM492.373

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
1999-06-30
2000-06-30 149 45
2001-06-30 599 599 2,292.766
2002-06-30 1,611.599 1,611.599 4,651.079
2003-06-30 1,028.243 1,028.243 5,058.609
2004-06-30 1,983 4,819.982
2005-06-30 295.552 40.527 295.552 6,545.704
2006-06-30 652.375 70.626 652.375 10,279.068
2007-06-30 817.295 144.758 817.295 11,989.857
2008-06-30 1,125.995 213.059 1,125.995 12,994.034
2009-06-30 3,610.495 337.621 3,610.495 12,257.551
2010-06-30 2,993.308 2,993.308 12,803.74
2011-06-30 3,183.179 3,183.179 14,063.786
2012-06-30 1,126.113 8,407 1,126.113 13,892.885
2013-06-30 1,637.207 14,925 1,637.207 22,956.564
2014-06-30 19,142.065 16,284 19,142.065 24,483.72
2015-06-30 6,629.113 23,181.79 6,629.113 34,735.208
2016-06-30 6,983.198 24,770.876 6,983.198 38,955.231
2017-06-30 5,375.625 24,223.275 5,375.625 34,251.299
2018-06-30 3,753.458 25,246.525 3,753.458 34,389.005
2019-06-30 3,824.426 8,977.465 3,824.426 20,891.718
2020-06-30 46.662 46.662 14,905.107
2021-06-30 13,021.853

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
1999-06-30 86 213 758 376
2000-06-30 4,537.28 5,307.946 245.925 50 7,401.919
2001-06-30 9,829.934 10,829.271 642.32 50 15,806.101
2002-06-30 8,624.119 15,838.595 5,849.737 5,007 19,097.738
2003-06-30 6,070.486 12,570.687 5,855.597 508.4 4,626 20,364.925
2004-06-30 8,703.415 14,961.612 6,030.721 508.4 4,626 26,155.308
2005-06-30 9,005.079 17,049.593 6,370.555 358.175 4,288 32,791.79
2006-06-30 4,728.227 19,714.759 8,768.481 413.83 3,967 38,037.759
2007-06-30 12,821.006 30,820.997 8,122.401 541.623 3,877 52,834.493
2008-06-30 6,280.48 28,313.4 6,785.975 572.168 3,536 56,098.888
2009-06-30 4,757.2 24,724.686 6,030.118 529.016 3,165 59,969.571
2010-06-30 12,612.244 31,514.471 6,048.583 626.944 2,692 75,114.469
2011-06-30 16,052.23 34,308.899 5,609.719 2,827.622 7 87,690.99
2012-06-30 17,336.609 31,102.188 5,203.071 732.819 444 87,834.778
2013-06-30 22,452.089 53,611.092 12,204.109 680.376 400 111,312.572
2014-06-30 10,500.307 65,060.617 20,242.01 788.6 506 111,721.671
2015-06-30 26,558.006 69,131.715 37,165.89 5,460.133 9,317.37 111,990.22
2016-06-30 45,450.382 88,010.018 45,576.972 3,874.157 18,436.72 134,392.813
2017-06-30 42,873.656 84,075.062 43,621.489 8,495.873 10,013.65 134,536.428
2018-06-30 24,930.461 65,065.829 48,107.974 5,833.855 15,736.33 135,211.955
2019-06-30 13,985.477 53,659.29 35,961.149 8,451.733 9,846.57 144,944.233
2020-06-30 4,577.747 34,462.856 21,780.849 5,952.847 6,258.99 148,156.005
2021-06-30 28,499.449 54,263.445 6,665.908 174.218 190,190.147

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
1999-06-30 -337 -18 104 86
2000-06-30 -1,418.874 4,451.044 86.236 4,537.28
2001-06-30 -3,279.252 -2,608.053 5,292.654 4,537.28 9,829.934
2002-06-30 -3,489.73 -2,912.47 -1,205.815 9,829.934 8,624.119
2003-06-30 -4,540.955 -2,553.633 8,624.119 6,070.486
2004-06-30 -3,574.582 -2,983.649 2,632.929 6,070.486 8,703.415
2005-06-30 -4,632.314 -3,333.015 301.664 8,703.415 9,005.079
2006-06-30 -5,396.95 -3,749.81 -4,276.852 9,005.079 4,728.227
2007-06-30 -5,449.798 -6,301.709 8,092.779 4,728.227 12,821.006
2008-06-30 -4,783.917 -6,613.069 -6,540.526 12,821.006 6,280.48
2009-06-30 -6,862.299 -4,986.123 -1,523.28 6,280.48 4,757.2
2010-06-30 -8,214.082 -7,099.625 7,855.044 4,757.2 12,612.244
2011-06-30 -9,356.497 -8,979.408 3,439.986 12,612.244 16,052.23
2012-06-30 -3,136.238 -4,014.142 1,284.379 16,052.23 17,336.609
2013-06-30 -10,001.35 -10,050.706 5,115.48 17,336.609 22,452.089
2014-06-30 3,206.616 -12,913.213 -11,950.782 22,452.089 10,501.307
2015-06-30 -16,949.405 4,936.118 16,945.226 9,567.307 26,512.533
2016-06-30 -16,608.757 -15,359.554 18,937.849 26,512.533 45,450.382 0
2017-06-30 -6,749.615 -1,439.842 -2,576.726 45,450.382 42,873.656 0
2018-06-30 -25,085.564 -20,452.793 -17,943.195 42,873.656 24,930.461
2019-06-30 -9,669.115 -15,581.904 -10,944.984 24,930.461 13,985.477
2020-06-30 -7,118.288 -3,903.193 -9,407.73 13,985.477 4,577.747
2021-06-30 -8,697.037 -7,538.724 23,921.702 4,577.747 28,499.449